Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03)

The summary for the Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03): The Division of Digestive Diseases and Nutrition (DDDN) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Division of Cancer Prevention of the National Cancer Institute encourage innovative clinical and epidemiological research into the role of Endoscopic Retrograde Cholangiopancreatography (ERCP) and other endoscopic and imaging techniques. Acute and chronic pancreatic and biliary diseases are common in the United States and account for considerable morbidity, mortality and health care costs. The spectrum of conditions includes those due to cancer of the exocrine and endocrine pancreas, gallstones, sludge, pancreatic and biliary malignancy, trauma, anatomic problems (pancreas divisum), alcohol and drugs and idiopathic syndromes such as idiopathic pancreatitis and sphincter of Oddi dysfunction. The recently held National Institutes of Health State-of-the-Science Conference Statement on ERCP indicated that while ERCP and other advanced endoscopic and imaging techniques have gained widespread application in clinical practice, there is little evidence based on rigorous clinical trials to guide the use of advanced diagnostic and therapeutic technologies in clinical practice decisions. The small grants (R03) may be used as planning grants for full-scale multi-center clinical trials or for pilot studies that could lead to full-scale multi-center clinical trials designed to provide evidence for or against changes in the current standard of care. Pilot epidemiological studies are encouraged that could lead to more extended research that would provide evidence for or against changes in health policy, especially as related to disease and cancer prevention. It is expected that these R03 grants will serve as a basis for planning future multi-center research project grant applications (R01) or cooperative agreement (U01) awards. New and experienced investigators in relevant fields and disciplines may apply for these small grants. Investigators are encouraged to take advantage of recent endoscopic and laboratory developments. In addition, the small grant is a good mechanism for new and experienced investigators to become better equipped to perform clinical and epidemiological research.
Federal Grant Title: Endoscopic Clinical Research In Pancreatic And Biliary Diseases (R03)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Food and Nutrition Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-06-171
Type of Funding: Grant
CFDA Numbers: 93.395
CFDA Descriptions: Cancer Treatment Research
Current Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Mar 02, 2006
Creation Date: Dec 05, 2008
Archive Date: Jun 01, 2009
Total Program Funding:
Maximum Federal Grant Award: $50,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical...
Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial ...
Assay development and screening for discovery of chemical probes, drugs or immunomodulator...
Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clini...
Breast and Prostate Cancer Data Quality and Patterns of Care Study
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults
National Cooperative Drug Discovery Groups for Cancer
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com